Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Hypertriglyceridemia, Increased VLDL cholesterol concentration, Hypopituitarism, and Precocious atherosclerosis and 2 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 1 | Increased VLDL cholesterol concentration |
Biomarker and diagnostic research for hypertriglyceridemia 1 has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include gene therapy. Pipeline includes 1 PHASE1. Research is primarily industry-sponsored.
170 publications have been identified in PubMed for hypertriglyceridemia 1. Research spans Epidemiology / Natural History (34%), Review / Meta-Analysis (25%), and Clinical Trial Publication (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 58 | 34% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 12:11 PM UTC
Online Mendelian Inheritance in Man
1 |
Increased VLDL cholesterol concentration |
Research summaries |
43 |
25% |
Clinical study results | 30 | 18% |
Laboratory research | 19 | 11% |
Patient case studies | 10 | 6% |
Testing and diagnosis research | 8 | 5% |
New treatment approaches | 2 | 1% |
Guo J (2026). [PMID: 41975355](https://pubmed.ncbi.nlm.nih.gov/41975355/). *BMC Public Health*. [Epidemiology / Natural History]
Hang S (2026). [PMID: 42007892](https://pubmed.ncbi.nlm.nih.gov/42007892/). *Expert Rev Cardiovasc Ther*. [Review / Meta-Analysis]
Masood MA (2026). [PMID: 42010647](https://pubmed.ncbi.nlm.nih.gov/42010647/). *Syst Rev*. [Review / Meta-Analysis]
Huang M (2026). [PMID: 42121140](https://pubmed.ncbi.nlm.nih.gov/42121140/). *BMC Med Genomics*. [Epidemiology / Natural History]
Larouche M (2026). [PMID: 40663639](https://pubmed.ncbi.nlm.nih.gov/40663639/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Albhaisi S (2026). [PMID: 41801201](https://pubmed.ncbi.nlm.nih.gov/41801201/). *JAMA Netw Open*. [Epidemiology / Natural History]
Toussaint R (2026). [PMID: 41999974](https://pubmed.ncbi.nlm.nih.gov/41999974/). *Clin Nutr ESPEN*. [Epidemiology / Natural History]
Yordanova SG (2026). [PMID: 41841805](https://pubmed.ncbi.nlm.nih.gov/41841805/). *Endokrynol Pol*. [Review / Meta-Analysis]
Marston NA (2026). [PMID: 41211918](https://pubmed.ncbi.nlm.nih.gov/41211918/). *N Engl J Med*. [Clinical Trial Publication]
Choe HJ (2026). [PMID: 41269040](https://pubmed.ncbi.nlm.nih.gov/41269040/). *Eur J Clin Invest*. [Review / Meta-Analysis]
AI-curated news mentioning hypertriglyceridemia 1
Updated Sep 12, 2026
A recent study evaluates the efficacy of plasma exchange and exchange transfusion for managing severe hypertriglyceridemia in emergency settings. The findings contribute to understanding treatment options for this condition.
A rare case study highlights the relationship between hypertriglyceridemia, chronic kidney disease, and proteinuria in a patient with apolipoprotein C-II amyloidosis. This research contributes to the understanding of the disease's impact on kidney function.
A recent study highlights the genetic predisposition to asparaginase-induced hypertriglyceridemia in children with acute lymphoblastic leukemia, presenting two case reports and a literature review. This research could inform future treatment strategies and monitoring for affected patients.
Arrowhead Pharmaceuticals reports promising results for its fat-lowering drug, showing safety and efficacy in reducing triglyceride levels and pancreatitis cases. Analysts believe these results position it competitively against Ionis' therapy.